Combination Treatment with Transcranial Magnetic Stimulation and Ketamine for Treatment-resistant Depression

You’re invited to join the Clinical TMS Society for this installment of our Grand Round Webinar Series: Combination Treatment with Transcranial Magnetic Stimulation and Ketamine for Treatment-resistant Depression

Presentation Overview: 

  1. To understand the literature on the mechanisms of action supporting combination treatment with TMS and ketamine
  2. To identify clinical situation in which combination treatment with TMS and ketamine may be warranted.
  3. To recognize where combination treatment with TMS and ketamine may fit in a treatment algorithm for medication refractory depression.

Date of Release: February 5, 2021

Date of Expiration: February 4, 2023

Format: ON-DEMAND

Cost: Members: $25 | Non-members $50 | Student Members FREE


SPEAKER: C. Sophia Albott, MD

Dr. C. Sophia Albott is the Deputy Vice Chair for Research and an Assistant Professor in the Department of Psychiatry & Behavioral Sciences at the University of Minnesota. Her research focuses on novel interventions (ketamine, transcranial magnetic stimulation, cognitive training) for treating mood (depression) and trauma-related disorders (PTSD). She published the first study of repeated ketamine infusions in veterans with PTSD and currently leads the first randomized controlled trial of repeated ketamine infusions for comorbid PTSD and depression. Dr. Albott’s research uses neuroimaging techniques (MRI) to evaluate structural and functional brain abnormalities in trauma-related disorders (PTSD, depression, secondary traumatic stress). She also established and leads the Ketamine Registry of Minnesota (KaRMa) which is a joint venture between the University of Minnesota and Mayo Clinic tracking long-term outcomes of patients receiving ketamine for depression. She maintains a part-time clinic at the MHealth Outpatient Neuromodulation Clinic where she also participates in clinical research translating her work on the pathophysiological mechanisms underlying disordered responses to trauma. She has received awards from the NIH and the University of Minnesota Medical School, and is currently funded through a K23 Career Development Award from the National Institute of Mental Health.


Acknowledgement of Financial and/or In-Kind Commercial Support

No financial or in-kind commercial support was received for this educational activity.

Satisfactory Completion 

Learners must complete an evaluation form to receive a certificate of completion. You must participate in the entire webinar as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.   

Physicians             

image-20191127111456-1.png

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the Clinical TMS Society. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Credit Designation Statement – Amedco LLC designates this enduring activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Questions? Email Certificate@AmedcoEmail.com

 

 

When
February 2nd, 2021 from  5:00 PM to  6:00 PM
Contact
Phone: 845-392-3238
Event Fee(s)
Fee Level
Webinar Registration | Non-Member $50.00